organic compounds
and O6) with disordered molecules on either side. Similarly, in
the parallel chain along the [001] direction, the disordered
molecule B forms chains with ordered molecules via OÐ
HÁ Á ÁO hydrogen bonds (involving atoms H4O and O3). The
crystal structure is stabilized by van der Waals forces between
parallel layers of molecules (Vasu et al., 2003).
In conclusion, the effect of different substituents on the
conformational preferences in a series of carboxamide deri-
vatives has been highlighted. Packing is mainly governed by
strong hydrogen bonds together with van der Waals inter-
actions.
The H atoms of the phenolic O atom, the amide N atom and the C
atom connected to the imine N atom were located in a difference
Fourier map and re®ned isotropically. The NÐH and OÐH bond
Ê
lengths are in the ranges 0.81 (2)±0.82 (2) and 0.84 (4)±0.86 (4) A,
respectively. The disordered C26 and C27 atoms of the cyclohexene
ring in molecule B were split with an initial occupany of 0.5 assigned
to each. The H atoms on C25 and C28 were also split with occu-
pancies of 0.5 and ®xed using the riding model. The remaining H
atoms were placed in calculated positions and allowed to ride on
Ê
their parent C atoms, with CÐH = 0.93±0.97 A and Uiso(H) = 1.2 or
1.5Ueq(C).
Data collection: SMART (Bruker, 2000); cell re®nement: SAINT
(Bruker, 2000); data reduction: SAINT; program(s) used to solve
structure: SIR92 (Altomare et al., 1993); program(s) used to re®ne
structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
ORTEP-3 for Windows (Farrugia, 1997) and CAMERON (Watkin et
al., 1993); software used to prepare material for publication:
PLATON (Spek, 2003).
Experimental
The title compound was synthesized using the Gewald reaction
(Gewald et al., 1966). o-Cyanotoluidine (0.04 mol) was re¯uxed with
ethyl methyl ketone in the presence of sulfur at 313±323 K for 1 h.
The product was then reacted with 4-hydroxy-5-methoxybenzalde-
hyde in an equimolar ratio in the presence of ethanol, which yielded
the title compound (68%). This was puri®ed by recrystallization from
ethyl acetate by slow evaporation, yielding orange needle-shaped
crystals of (I).
The authors thank Professor T. N. Guru Row, Indian
Institute of Science, Bangalore, and the Department of
Science and Technology, India, for data collection on the CCD
facility under the IRHPA±DST scheme. Vasu thanks Viveka-
nanda Degree College for support and DC thanks the CSIR
and IISc for a Senior Research Fellowship.
Crystal data
3
Ê
C24H24N2O3S
Mr = 420.52
V = 4271 (4) A
Z = 8
Monoclinic, P21=n
Mo Kꢂ radiation
ꢃ = 0.18 mm
T = 290 (2) K
0.18 Â 0.09 Â 0.08 mm
1
Ê
a = 14.817 (8) A
Ê
b = 13.701 (8) A
Supplementary data for this paper are available from the IUCr electronic
archives (Reference: AV3133). Services for accessing these data are
described at the back of the journal.
Ê
c = 22.224 (13) A
ꢁ = 108.807 (11)ꢀ
Data collection
Bruker SMART CCD area-detector
diffractometer
Absorption correction: multi-scan
(SADABS; Sheldrick, 1996)
Tmin = 0.936, Tmax = 0.986
30379 measured re¯ections
7512 independent re¯ections
4900 re¯ections with I > 2ꢄ(I)
Rint = 0.037
References
Altomare, A., Cascarano, G., Giacovazzo, C. & Guagliardi, A. (1993). J. Appl.
Cryst. 26, 343±350.
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem.
Int. Ed. Engl. 34, 1555±1573.
Re®nement
Bruker (2000). SMART (Version 5.0) and SAINT (Version 6.02). Bruker AXS
Inc., Madison, Wisconsin, USA.
R[F2 > 2ꢄ(F2)] = 0.053
wR(F2) = 0.134
S = 1.02
7512 re¯ections
587 parameters
H atoms treated by a mixture of
independent and constrained
re®nement
Cohen, V. I., Rist, N. & Duponchel, C. (1977). J. Pharm. Sci. 66, 1332±1334.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354±1358.
Csaszar, J. & Morvay, J. (1983). Acta Pharm. Hung. 53, 121±128.
Dzhurayev, A. D., Karimkulov, K. M., Makhsumov, A. G. & Amanov, N.
(1992). Khim. Farm. Zh. 26, 73±75.
3
Ê
Áꢅmax = 0.28 e A
3
Ê
0.25 e A
Áꢅmin
=
El-Maghraby, A. A., Haroun, B. & Mohammed, N. A. (1984). Egypt. J. Pharm.
Sci. 23, 327±336.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
Table 1
Selected bond lengths (A).
Ê
Gewald, K., Schinke, E. & Botcher, H. (1966). Chem. Ber. 99, 94±100.
Kumar, G. N. A., Kokila, M. K., Puttaraja,, Mohan, S., Shetty, K. S. M. &
Kulkarni, M. V. (2005). Acta Cryst. E61, o69±o71.
Lakshmi, V. V., Sridhar, P. & Polasa, H. (1985). Indian J. Pharm. Sci. 47, 202±
204.
N1ÐC7
N1ÐC8
N2ÐC16
N2ÐC23
1.283 (3)
1.384 (3)
1.342 (3)
1.431 (3)
N3ÐC32
N3ÐC31
N4ÐC41
N4ÐC42
1.277 (3)
1.388 (3)
1.344 (3)
1.424 (3)
Pellis, G. & West, G. B. (1968). Progress in Medicinal Chemistry, Vol. 5, pp.
320±324. London: Butterworth and Co. Ltd.
È
Sheldrick, G. M. (1996). SADABS. University of Gottingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112±122.
Spek, A. L. (2003). J. Appl. Cryst. 36, 7±13.
Vasu, Nirmala, K. A., Chopra, D., Mohan, S. & Saravanan, J. (2004a). Acta
Cryst. C60, o786±o788.
Table 2
Hydrogen-bond geometry (A, ).
ꢀ
Ê
Cg1 is the centroid of the C17±C23 ring.
DÐHÁ Á ÁA
DÐH
HÁ Á ÁA
DÁ Á ÁA
DÐHÁ Á ÁA
Vasu, Nirmala, K. A., Chopra, D., Mohan, S. & Saravanan, J. (2004b). Acta
Cryst. C60, o636±o638.
N4ÐH4NÁ Á ÁN3
N2ÐH2NÁ Á ÁN1
O4ÐH4OÁ Á ÁO3i
O1ÐH1OÁ Á ÁO6ii
C35ÐH35Á Á ÁCg1iii
0.81 (3)
0.82 (3)
0.86 (4)
0.88 (4)
0.93
2.05 (3)
2.06 (3)
1.83 (4)
1.82 (4)
2.89
2.738 (3)
2.748 (4)
2.683 (3)
2.697 (3)
3.670 (3)
143 (2)
141 (2)
171 (4)
174 (3)
143
Vasu, Nirmala, K. A., Chopra, D., Mohan, S. & Saravanan, J. (2005). Acta
Cryst. E61, o236±o238.
Vasu, Nirmala, K. A., Choudhury, A. R., Mohan, S., Saravanan, J. &
Narasimhamurthy, T. (2003). Acta Cryst. C59, o676±o678.
Watkin, D. M., Pearce, L. & Prout, C. K. (1993). CAMERON. Chemical
Crystallography Laboratory, University of Oxford, England.
1
2
Symmetry codes: (i) x
;
y 12; z 12; (ii) x 21; y 21; z 12; (iii) x 1; y; z.
ꢁ
o186 Vasu et al. C24H24N2O3S
Acta Cryst. (2008). C64, o184±o186